Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use

AstraZeneca5,234 enrolled

Overview

The purpose of the study is to examine the impact of augmented, high-quality physician-coordinated care executed via an electronic health record (EHR)-based intervention on quality of care for gastroesophageal reflux disease (GERD) and for gastroprotection for patients on chronic non-steroidal anti-inflammatory drugs (NSAIDs) at increased risk for upper GI tract ulcers and ulcer related complications.

Study Type

OBSERVATIONAL

Enrollment

5,234

Conditions

GERD

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Eligibility as determined by criteria for participation in studies as part of the MQIC * Agreement of participating clinical practices to undergo training in the electronic health record (EHR) intervention designed for this study Exclusion Criteria: * Based on voluntary participation by MQIC practices, so practices were excluded if they decided to opt out